Drugs.com

DECEMBER 27, 2023

27, 2023 -- When hospitals support trauma survivors' mental health during and after treatment, patients are less likely to return in crisis, researchers report.There's no uniform guidance on how to offer mental health services to. WEDNESDAY, Dec.

Hospitals 98

Hospitals Treatment Research 98

Drug Discovery World

DECEMBER 18, 2023

A new study has shown why seven in 10 women experience nausea and vomiting during pregnancy – and why some women become so sick they need to be admitted to hospital. Hyperemesis gravidarum, or severe vomiting, is the commonest cause of admission to hospital of women in the first three months of pregnancy.

Treatment 130

Treatment Hospitals International Science 130

Drug Discovery World

OCTOBER 2, 2023

The European Commission (EC) has approved INAQOVI (oral decitabine and cedazuridine) as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) who are ineligible for standard induction chemotherapy.

Treatment 130

Treatment Pharmacokinetics Clinical Trials Licensing 130

Drug Discovery World

JANUARY 31, 2024

While there has been successful development of intravitreally administered products for patients with late-stage disease, treatment options are currently limited for patients in the early or moderate stages. Breye is developing novel, oral ophthalmology drugs fordiabetic retinopathy (DR) or age-related macular degeneration (AMD).

Treatment 130

Treatment Clinical Trials Pharmacokinetics Trials 130

Drug Discovery World

MARCH 21, 2024

It found that patients with rare kidney diseases are 28 times more likely to experience kidney failure than those with chronic kidney disease (CKD), but are less than half as likely to die before kidney failure treatment is needed. Rare kidney diseases are a group of conditions that each affect fewer than one in 2,000 people.

Disease 130

Disease Treatment Hospitals Therapies 130

Drug Discovery World

NOVEMBER 25, 2022

According to the partnership between the University of Birmingham and Acticor Biotech, the trial will take place in two hospitals in the UK: the Queen Elizabeth Hospital, Birmingham and the Northern General Hospital, Sheffield.

Trials 130

Trials Treatment Hospitals Laboratories 130

Common Sense for Drug Policy Blog

OCTOBER 7, 2023

Changes in the risk of hospital admissions with injecting-related infections in and out of prison and OAT may also reflect changes in the ability to access primary and secondary health services. 2012 ; Joudrey et al., 2019 ; Treloar et al., 2014 ; Joudrey et al., 2019 ), which likely increases overdose risk more so than infection risk.

Hospitals 52

Hospitals Treatment International Drugs 52

KIF1A

MAY 29, 2024

Fortunately, Sloane does not currently have epilepsy, and Megan hopes this treatment will prevent it’s onset as her disease progresses. On the day of the treatment, they checked into the hospital where Sloane was administered sedation medication. The post Sloane’s 1st ASO treatment appeared first on KIF1A.

Treatment 52

Treatment Doctors Hospitals Therapies 52

Drug Discovery World

JANUARY 30, 2023

The primary objectives of MOVE were to evaluate the efficacy of palovarotene in reducing new HO volume, as assessed using whole-body computed tomography. “There is a significant need for a treatment specifically developed to help manage the progression of this disease.

Treatment 130

Treatment Disease Clinical Trials Trials 130

Drug Discovery World

SEPTEMBER 16, 2022

The drug candidate is an inhibitor of protein kinases TBK1 and IKK-epsilon, which previous studies suggest should be highly-effective in the treatment of inflammatory diseases. The post UK company identifies potential new treatment for lupus appeared first on Drug Discovery World (DDW).

Treatment 130

Treatment Laboratories Hospitals Disease 130

Drug Discovery World

OCTOBER 10, 2022

A new clinical trial, led by the University of Glasgow and NHS Greater Glasgow and Clyde (NHSGGC), hopes to improve treatment options for patients with Crohn’s disease. . Unfortunately, no currently available treatment provides an effective solution for all patients. Official comments.

Disease 130

Disease Treatment Hospitals Therapies 130

Drug Discovery World

SEPTEMBER 15, 2022

A new combination therapy could represent a significant advancement in the treatment of metastatic colorectal cancer. million per year,” said Professor Josep Tabernero, Head of Medical Oncology, Vall d’Hebron University Hospital, Barcelona, Spain, and Primary Investigator for the SUNLIGHT trial. .

Trials 130

Trials Treatment Clinical Trials Hospitals 130

Drug Discovery World

SEPTEMBER 13, 2022

The findings were presented at the European Society for Medical Oncology (ESMO) Congress 2022 by Professor Robin Jones, MD, Head of the Sarcoma Unit at The Royal Marsden Hospital, London. The post New treatment hope for patients with rare tumours appeared first on Drug Discovery World (DDW).

Treatment 130

Treatment FDA Approval Clinical Trials Hospitals 130

Drug Discovery World

JULY 11, 2022

Pharmaceutical company Novo Nordisk has announced positive results for its prophylactic treatment targeting people living with haemophilia A or B with inhibitors. . The company’s concizumab treatment is an anti-tissue factor pathway inhibitor (TFPI)? The treatment of haemophilia is complex and no one treatment fits all, ” ?

Treatment 130

Treatment Pharmaceutical Companies Hospitals Trials 130

Drug Discovery World

JULY 5, 2024

The Division of Clinical Neuroscience at Oslo University Hospital (OUS) and the Swedish drug development company TikoMed have signed a research collaboration agreement focused on amyotrophic lateral sclerosis (ALS).

Drug Research 204

Drug Research Research Hospitals Drugs 204

Drug Discovery World

FEBRUARY 9, 2023

Launched in 2020, the Oxford-based business hopes the designation will “open regulatory discussions, supplement funding, increase the viability of drug development and enable quick access to market a treatment.” SynaptixBio CEO and co-founder Dr Dan Williams said the designation was a “monumental step forward” in its bid to treat the disease.

Treatment 130

Treatment Disease Clinical Trials FDA 130

Drug Discovery World

AUGUST 23, 2022

The European Medicines Agency (EMA) has granted a Marketing Authorisation Application (MAA) for a combination treatment targeting adults with acute myeloid leukaemia (AML) who are not candidates for standard induction chemotherapy. . Poster presented at EHA Annual Meeting, Vienna, Austria June 9 – 12, 2022. Abstract P573.

Treatment 130

Treatment Pharmacokinetics Clinical Trials DNA 130

Drug Discovery World

DECEMBER 16, 2022

The treatment of multiple myeloma becomes more complex with each relapse, so it is critical for frontline therapy to achieve deep treatment responses and extend survival,” said Edmond Chan, EMEA Therapeutic Area Lead Haematology, Janssen-Cilag Limited. Phase Ib MajesTEC-2 trial . Phase III GLOW study .

Trials 130

Trials Treatment Clinical Trials Therapies 130

Drug Target Review

JANUARY 23, 2024

What innovative approaches and technologies are anticipated to reshape immuno-oncology treatments in 2024? Immuno-oncology, notably through checkpoint inhibitors, has significantly reshaped cancer treatment over the past decade. Espen integrates clinical and research expertise as Director of Medical Affairs.

Treatment 122

Treatment Immune Response Vaccine Therapies 122

Drug Discovery World

SEPTEMBER 13, 2024

The consortium so far includes Yemaachi Biotech, Pediatric Oncology Units at Korle Bu Teaching Hospital, Komfo Anokye Teaching Hospital and Greater Accra Regional Hospital, and institutions like Newcastle University, UK.

Hospitals 147

Hospitals Clinical Research Treatment Research 147

Drugs.com

MARCH 21, 2024

THURSDAY, March 21, 2024 -- People with heart disease can stay healthier if they address their emotional problems as well as their physical ailments, a new study says.Treating anxiety and depression reduced ER visits and hospitalizations among.

Treatment 116

Treatment Hospitals Disease 116

Drug Discovery World

AUGUST 29, 2024

The benefits of Alzheimer’s drug lecanemab (Leqembi) are too small to justify the cost of providing the treatment to NHS patients, the UK regulator has ruled. However, the reality is that the benefits this first treatment provides are just too small to justify the significant cost to the NHS.

Regulations 147

Regulations Hospitals Licensing Licensing 147

Broad Institute

JULY 11, 2024

Targeted drug treatment leads tumor cells to imitate viral infection By Ari Navetta July 11, 2024 Breadcrumb Home Targeted drug treatment leads tumor cells to imitate viral infection Exploiting "viral mimicry," mIDH1 inhibitors trick tumors into thinking they are infected with a virus. paper cited Wu M, Kondo H, et al.

Treatment 72

Treatment Immune Response Virus Drugs 72

Drug Discovery World

JULY 13, 2022

The first new treatment in 20 years that prevents a common, painful side-effect in patients with sickle cell disorder (SCD) has been issued interim acceptance by the Scottish Medicines Consortium (SMC). . Many people with sickle cell disease experience recurrent painful crises which can result in hospital admission.

Treatment 130

Treatment Hospitals Disease International 130

Drugs.com

MAY 20, 2024

MONDAY, May 20, 2024 -- Women treated for infertility were twice as likely as those who conceived naturally to be hospitalized with heart disease within a year of delivery, recent research shows.They are particularly likely to land in the hospital.

Treatment 69

Treatment Hospitals Disease Research 69

SCIENMAG: Medicine & Health

SEPTEMBER 22, 2023

A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial.

Clinical Trials 52

Clinical Trials Hospitals Trials Treatment 52

Common Sense for Drug Policy Blog

JULY 21, 2023

Residential Treatment Compared With Outpatient Treatment Coupled With MOUD "Residential treatment is often considered the highest intensity of treatment for individuals with OUD [ 40 ], and may by particularly important for those with unstable housing, co-morbid mental health conditions, or high medical need [ 41 ].

Treatment 52

Treatment Hospitals Research 52

Drug Discovery World

JUNE 19, 2024

KYV-101, a fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, has been used to treat a 69-year-old patient suffering from treatment-refractory stiff-person syndrome (SPS). The treatment was well tolerated and led to a significant improvement in walking distance and 40% reduction in GABAergic medications. “It

Therapies 246

Therapies Disease Hospitals Treatment 246

Drug Target Review

FEBRUARY 21, 2024

This is a time when several promising treatments – including mRNA vaccines, BiTE therapies and CAR-T cell therapy, are essentially in competition with each other – they all have a common goal of treating the same disease, but they are approaching the objective from different angles.

Therapies 64

Therapies Treatment Vaccine FDA Approval 64

Drug Target Review

AUGUST 29, 2024

However, these treatments will eventually fail for the majority of patients, so there is a strong need for better CAR therapies. How might the CD5 knockout approach impact the treatment of other types of cancers beyond T-cell lymphoma?

Therapies 59

Therapies Treatment Engineering Molecular Biology 59

National Drug & Alcohol Research Centre Blog

DECEMBER 4, 2023

Kendal Chidwick NDARC’s Kendal Chidwick discusses the findings from a recently published study that examined how patterns of opioid agonist treatment medicines have changed over the past decade. Other changes around this time aimed at improving treatment accessibility included increased use of take-home doses and telehealth appointments.

Treatment 133

Treatment Community Pharmacies Pharmacy International 133

Drug Discovery World

JUNE 25, 2024

The paper was co-authored by analytics company Phesi and Dr Yi-Bin Chen, Director for the Blood and Marrow Transplant Program at Massachusetts General Hospital. Phesi created a digital twin for chronic graft versus host disease (cGvHD) in the primary treatment setting.

Clinical Trials 147

Clinical Trials Trials Hospitals Clinical Research 147

Drug Discovery World

SEPTEMBER 13, 2024

This week, DDW has opened registrations for its webinar ‘ The latest advancements driving neuroscience drug discovery research ’, so our news highlights focus on developments in neuroscience, including a novel drug that has been shown to reduce neuronal death, and a potential disease-modifying treatment for dementia.

Drugs 147

Drugs Disease Hospitals Treatment 147

Drug Discovery World

NOVEMBER 22, 2022

Leading cause of hospital infections. This species is one of the leading causes of infections in hospitals, and one that is particularly good at resisting antibiotics. . During their stay in hospital the patient was treated with the antibiotic Meropenem for a suspected urinary tract infection (UTI). AMR pathogens in the gut.

Hospitals 246

Hospitals Treatment Research Drugs 246

Science Daily: Pharmacology News

DECEMBER 13, 2023

A new study has shown why many women experience nausea and vomiting during pregnancy -- and why some women, including the Duchess of Cambridge, become so sick they need to be admitted to hospital. The culprit is a hormone produced by the fetus -- a protein known as GDF15.

Treatment 86

Treatment Hospitals 86

Drug Discovery World

OCTOBER 17, 2023

CARsgen has published evidence of over seven years of disease-free survival in advanced hepatocellular carcinoma (HCC) following treatment with its CAR-GPC3 T cell therapy. For HCC patients with concurrent inferior vena cava tumour thrombus, treatment options are limited and overall prognosis is poor. months postoperatively.

Therapies 162

Therapies Hospitals Treatment Virus 162

Drug Discovery World

MAY 28, 2024

Researchers from The University of Queensland and the Queensland Children’s Hospital (QCH) have successfully tested the first-in-class drug in mice. A new drug could prevent sepsis-related organ failure and death by restoring the health of a patient’s blood vessels.

Immune Response 147

Immune Response Hospitals Drugs Clinical Trials 147